Bert Spilker
Impact in
- Economics and Econometrics top 1%
- Health Systems, Economic Evaluations, Quality of Life
- Family Practice top 5%
Papers in
-
- Pharmaceutical Economics and Policy 8
- Health Systems, Economic Evaluations, Quality of Life 7
-
- Cardiac electrophysiology and arrhythmias 11
- Co-authors
- Enoch Callaway (3 shared papers)Joyce A. Cramer (2 shared papers)Anthony C. Segreti (1 shared paper)K. M. Dhasmana (4 shared papers)Kenneth J. Blackburn (1 shared paper)Roger A. Burges (1 shared paper)Bita V. Naini (1 shared paper)Alan L. Buchman (1 shared paper)
- Journals
- British Journal of Pharmacology (5 papers)European Journal of Pharmacology (3 papers)JAMA (3 papers)Cellular and Molecular Life Sciences (3 papers)Drug News & Perspectives (3 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Bert Spilker
63 papers receiving 2.6k citations
Bert Spilker's Hit Papers
Peers
Comparison fields: 5 of 137
- Economics and Econometrics 650
- Family Practice 54
- Psychiatry and Mental health 181
- Statistics and Probability 98
- Pediatrics, Perinatology and Child Health 99
Countries citing papers authored by Bert Spilker
This map shows the geographic impact of Bert Spilker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Spilker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Spilker more than expected).
Fields of papers citing papers by Bert Spilker
This network shows the impact of papers produced by Bert Spilker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Spilker. The network helps show where Bert Spilker may publish in the future.
Co-authors
The 25 scholars most cited alongside Bert Spilker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quality of life and pharmacoeconomics in clinical trials Hit paper breakdown → | 1996 | 1728 |
| 2 | Guide to clinical trials | 1991 | 271 |
| 3 | 1993 | 170 | |
| 4 | 1992 | 65 | |
| 5 | Quality of Life and Pharmacoeconomics: An Introduction | 1998 | 53 |
| 6 | 1969 | 49 | |
| 7 | Patient recruitment in clinical trials | 1992 | 46 |
| 8 | 1969 | 42 | |
| 9 | 1969 | 34 | |
| 10 | 1969 | 33 | |
| 11 | 2017 | 32 | |
| 12 | 1984 | 29 | |
| 13 | 1996 | 25 | |
| 14 | Introduction to the field of quality of life trials | 1990 | 21 |
| 15 | 1992 | 20 | |
| 16 | 1970 | 19 | |
| 17 | 1973 | 19 | |
| 18 | 1969 | 15 | |
| 19 | 1976 | 14 | |
| 20 | Guide to clinical interpretation of data | 1986 | 14 |
About Bert Spilker
Bert Spilker is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine, Statistics and Probability, Pharmacology and Family Practice, having authored 65 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (11 papers), Pharmaceutical Economics and Policy (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), Receptor Mechanisms and Signaling (7 papers), Statistical Methods in Clinical Trials (6 papers), Pharmaceutical industry and healthcare (5 papers), Asthma and respiratory diseases (4 papers) and Phosphodiesterase function and regulation (4 papers). The work is most often cited by research in Economics and Econometrics (650 citations), Family Practice (54 citations), Psychiatry and Mental health (181 citations), Statistics and Probability (98 citations) and Pediatrics, Perinatology and Child Health (99 citations). Bert Spilker has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Enoch Callaway, Joyce A. Cramer, Anthony C. Segreti, K. M. Dhasmana, Kenneth J. Blackburn, Roger A. Burges, Bita V. Naini, Alan L. Buchman, D. JOHN COLTART and Charles L. Yeager. Their work appears in journals such as British Journal of Pharmacology, European Journal of Pharmacology, JAMA, Cellular and Molecular Life Sciences and Drug News & Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.